Clinical Trials · NCT01511172
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 145
- Start date
- Aug 2002
- Locations
- 41 sites, 8 countries
- Primary endpoint
- Fasting plasma/serum glucose